Clinical analysis of 35 cases of intracerebral hemangiopericytomas prognosis

Yafei Xue,Yingxi Wu,Lanfu Zhao,Wenhai Lv,Tianzhi Zhao,Yuan Wang,Lei Chen,Shiming He
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.01.008
2018-01-01
Journal of Modern Oncology
Abstract:Objective:To explore and summarize efficacy in treatment and prognosis of intracranial hemangioperi-cytomas (HPCs). Methods:Clinical data of 35 cases of HPCs in the central nervous system were analyzed retrospec-tively. All surgeries were performed under microscope and the critical factors which affect prognosis of HPCs were studied by statistical analysis. Results:The median survival for all patients was 82. 4 months after date of diagnosis, with 1 - year,5 - year,10 - year survival rates of 100%,93. 8% and 72. 4%,respectively. Thirteen patients had HPCs recurrence. The median time of recurrence was 65. 4 months,with 1 - year,5 - year and 10 - year progression -free survival rates of 99%,49%,31% . Three patients developed extracranial metastasis. Patients undergoing any form of adjuvant radiation treatment had no longer overall survival (P = 0. 22),but had a significantly improved progression- free interval (P = 0. 04). Tumor characteristics associated with earlier recurrence included size ≥6 cm and sinus invasion. Conclusion:Surgeries combining adjuvant radiation with tumor resection appeared to inhibit tumor progres-sion ,but had no effect on overall survival.Greater extent of resection was related to increased overall survival (P < 0. 05). Anaplastic HPC was associated with reduced overall survival and with reduced recurrence interval (P < 0. 05).
What problem does this paper attempt to address?